A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis
Status:
Completed
Trial end date:
2019-09-25
Target enrollment:
Participant gender:
Summary
A 4-week, Randomized, Double-blind, Multicenter, Placebo-controlled Phase 2 Study to Evaluate
the Efficacy and Safety of HP-5000 in Subjects with Osteoarthritis (OA) of the Knee